Hamilton Lane Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,171
Closed -$1.36M 38
2019
Q4
$1.36M Buy
+2,171
New +$1.06M 0.6% 27
2018
Q4
Sell
-2,398
Closed -$1K 49
2018
Q3
$1K Buy
+2,398
New +$516K 0.41% 27

Other funds holding CDLX

Hamilton Lane Advisors's CDLX Position: Q1 2020 in Review

Hamilton Lane Advisors sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 2,171 shares — an estimated $1.36M sold.

Hamilton Lane Advisors first reported a position in CDLX in Q3 2018 and held it in 2 quarters. The position peaked at $1.36M in Q4 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

  • Hamilton Lane Advisors reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
  • Hamilton Lane Advisors sold 2,171 Cardlytics shares in Q1 2020, an estimated $1.36M.
  • Hamilton Lane Advisors first reported a position in Cardlytics in Q3 2018 and held it in 2 quarters.
  • Hamilton Lane Advisors's Cardlytics position peaked at $1.36M in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on Hamilton Lane Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.